Eyal Shamir

Groundbreaking tumor treatment technology receives FDA clearance

Israeli medical device company IceCure plans to significantly extend its U.S. operations with its cryoablation technology to destroy benign and cancerous tumors by freezing. One America’s Stephanie Myers spoke with the CEO of IceCure, Eyal Shamir, who explained how this is a significant achievement for the company and how the technology works.